Abstract
Selective neutron capture therapy (NCT) using specific dopa analog,10B-p-boronophenylalanine (10B-L-BPA) for malignant melanoma of the skin was developed and achieved many cures by Mishima and his group1,2. We had developed 18F-10B-L-Boronophenylalanine which can not only provide selective detection and three dimensional imaging, but also 10B concentration dynamics clinically using positron emission tomography (PET)3,4,5. The purpose of this study is to explore NCT of melanoma brain metastasis using this compound.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Y. Mishima, M. Ichihashi, S. Hatta, C. Honda, K. Yamamura and T. Nakagawa. New thermal neutron capture therapy for malignant melanoma; melanogenesis-seeking 10B molecule -melanoma cell interaction from in vivo to first clinical trial. Pig Cell Res 2: 226–234, 1989
Y. Mishima, C. Honda, M. Ichihashi, H. Obara, H. Hiratsuka, H. Fukuda, H. Karashima, T. Kobayashi, K. Kanda and Y. Yoshino. Treatment of malignant melanoma by single neutron capture therapy with melanoma-seeking 1°B-Compound. Lancet II: 388–389, 1989
K. Ishiwata, T. Ido, K. Kawamura, K. Kubota, M. Ichihashi and Y. Mishima. 4-Borono-2-[18F] fluoroD-L-phenylalanine as a target compound for neutron capture therapy: tumor imaging potential with positron emission tomography. Nucl Med Biol 18: 745–751, 1991
K. Ishiwata, M. Shiono, K. Kubota, K. Yoshino, J. Hatazawa, T. Ido, C. Honda, M. Ichihashi, and Y. Mishima. A unique in vivo assessment of 4-[1°B]borono-L-phenylalanine in tumor tissue for boron neutron capture therapy of malignant melanoma using positron emission tomography and 4-borono-2[18F]fluoro-L-phenylalanine. Melanoma Res 2: 171–179, 1992.
Y. Mishima, Y. Imahori, C. Honda, S. Ueda, and T. Ido. In vitro diagnosis of human malignant melanoma using specific melanoma-seeking 18F-compound with positron emission tomography. Kyoto Univ Res Reactor Inst Tech Rep 374: 1–10, 1993
S. Somaza, D. Konzdiolka, L. D. Lunsford, J. M. Kirkwood and J. C. Flickinger. Stereotactic radiosurgery for cerebral metastatic melanoma, J Neurosurg 79: 661–666, 1993
R. G. Bristow, P. A. Hardy, and R. P. Hill. Comparison between in vitro radiosensitivity and in vivo radioresponse of murine cell lines: 1, Parameters of in vitro radiosensitivity and endogenous cellular glutathione levels. Int J Radiat Oncol Biol Phys 18: 133–145, 1990
B. Larsson. Radiobiological fundamentals in radiosurgery. In Radiosurgery: baseline and trends: ed. L. Steiner et al., Raven Press, New York 3–14, 1992
K. Matalka, M. Q. Bailey, R. F. Barth, A. E. Staubus, A.H. Soloway, M.L. Moeschberger, J. A. Codere and E. K. Rofstad. Boron neutron capture therapy of intracerebral melanoma using boronophenylalanine as a capture agent. Cancer Res 53: 3308–3313, 1993
R. F. Barth, K. Z. Matalka, M. Q. Bailey, A. E. Staubus, A. H. Soloway, M. L. Moeschberger, J. A. Codere and E. K. Rofstad. A nude rat model for neutron capture therapy of human intracerebral melanoma. Int J Radiat Oncol Biol Phys 28: 1079–1088, 1994.
J. L. Mallesch, B. P. Hons, D. E. Moore, B. J. Allen, W. H. McCarthy, R. J.Jones, and W. A. Stening. The pharmacokinetics of p-boronophenylalanine-fructose in human patients with glioma and metastatic melanoma. Int J Radiat Oncol Biol Phys 28: 1183–1188, 1994
R. V. Dorn. Boron neutron capture therapy (BNCT): a radiation oncology perspective. Int J Radiat Oncol Biol Phys 28, 1189–1201, 1994
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer Science+Business Media New York
About this chapter
Cite this chapter
Ehara, K. et al. (1996). Selective Detection of Brain Metastasis of Malignant Melanoma Using 18F-10B-L-Borono-Phenylalanine with Positron Emission Tomography. In: Mishima, Y. (eds) Cancer Neutron Capture Therapy. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-9567-7_117
Download citation
DOI: https://doi.org/10.1007/978-1-4757-9567-7_117
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-9569-1
Online ISBN: 978-1-4757-9567-7
eBook Packages: Springer Book Archive